Document resource
Background and Importance Clinical pharmacists play a key role in supporting complex patients such as lung transplant patients (LTPs).Aim and Objectives We would like to describe the integration of clinical pharmacists in therapeutic patient education for LTPs through pharmaceutical consultations (PCs).Material and Methods This is a retrospective study conducted from January to September 2025. We collected data on the characteristics of the PCs and the LTPs’ knowledge of their post-transplant treatment. Following multidisciplinary meetings, 3 PCs were implemented: PC1 was informative, using a table modelling an interactive medication plan; PC2 allowed patients to mobilise their knowledge using Barrows cards and PC3 provided medication information sheets before patients returned home.Results We included 35 patients, representing 100% of the cohort of patients who received a lung transplant during the study period. The male-to-female ratio was 1.9 and the average age was 57 years. 100% were on tacrolimus and corticosteroids and 97% were on mycophenolate mofetil (MMF). A total of 89 PC were conducted with an average of 2.5 PC per patient at 2 months post-transplant: 100% received a PC1, 91% a PC2, and 63% a PC3. Each of the three PC was performed with an average time of 43 minutes. During PC2, respectively 78% and 65% were aware of the importance of immunosuppressants and prophylaxis treatments. 87% were aware of how to take the medication and 90% of the importance of dosing and blood tests. The subject of procreation was discussed in 54% of women of childbearing age and menConclusion and Relevance All patients who had received a lung transplant were seen by the clinical pharmacist. Most of them were seen twice or more if necessary. PC3 was not conducted systematically as it was often combined with PC2. The key points concerning post-transplant medications were discussed and appear to have been well understood by patients following PC1. The subject of procreation was not discussed systematically, even though the majority of patients are on MMF and are concerned about its teratogenic risk. A review of the organisation should be carried out to enable all patients to benefit from at least two PC and to address the subject of procreation in a systematic manner.Conflict of Interest No conflict of interest